Advertisement

Topics

China Development Financial Holding Corporation Company Profile

04:13 EST 19th December 2018 | BioPortfolio

CDIB pioneered venture capital and investment banking in Taiwan and today it remains the predominant leader in venture capital business in Taiwan with a market share of over 30%. Along with Taiwan’s industrial development, CDIB has built up a wealth of experience in high-tech investment while its investment overseas has extended to the US, Japan, Korea and S.E. Asia.

Location

Nanking East Road, Section 5
Taipei
Taiwan
R.O.C125
China

Contact

Phone: 886-2-2763-8800
Fax: 886-2-2756-2144
Email: ir@cdibh.com


News Articles [2444 Associated News Articles listed on BioPortfolio]

Medlinker Raises $147 Million for China MD-Peer Online Network

Medlinker of Chengdu raised $146.8 million in a Series D round to support its online China MD peer network. Founded in 2014, Medlinker is designed to allow doctors to share their expertise, experience...

Roche's NSCLC therapy approved in China

China's State Drug Administration granted approval to Roche Holding's Alecensa, or alectinib, as monotherapy for the treatmen -More- 

Virbac: Availability of the quarterly financial information as of September 30, 2018

Virbac: Availability of the quarterly financial information as of September 30, 2018 Public release - November 14, 2018 The quarterly financial information as of September 30, 2018 is avai...

Fountain Medical Development: Clinical trials, government involvement and China's future

In this interview, filmed at BioPharm in San Francisco, Dr Fintan Walton speaks with Joanne Jiang, Executive Vice President at Fountain Medical Development, a new contract research organisation in Chi...

China’s Emergence Into the Global Pharma Industry

Recently big pharma have been taking advantage of the financial and industrial environment in China. In this interview Fintan Walton and Dr. Bill Guo, founder and Chairman of Venturepharm, take a look...

China YCT International Group, Inc.: China YCT International Group Reports Fiscal Year 2018 Financial Results

SISHUI COUNTY, CHINA / ACCESSWIRE / June 29, 2018 / China YCT International Group, Inc. (OTCQB: CYIG) (the "Company) today announced its financial results for the fiscal year ended March 31, 2018. ...

Once significantly behind, China begins to close the drug development gap

Moving forward, China will take a more integral role in global drug development, following several regulatory changes designed to accelerate innovation.

Ditech Holding Corporation Announces Second Quarter 2018 Highlights And Financial Results

FORT WASHINGTON, Pa., Aug. 9, 2018 /PRNewswire/ -- Ditech Holding Corporation (NYSE: DHCP) today announced a net loss for the quarter ended June 30, 2018 Read more...

PubMed Articles [2364 Associated PubMed Articles listed on BioPortfolio]

Individual investment decision behaviors based on demographic characteristics: Case from China.

Predicting and analyzing behaviors of investors is of great value to financial institutions. This paper uses survey data from about 9,000 individual investors across China to explore the predictabilit...

Critical Illness Insurance to alleviate catastrophic health expenditures: new evidence from China.

Currently, a high percentage of China's households face financial catastrophe as a direct result of excessive out-of-pocket (OOP) health expenditures. To alleviate this, China has set up the Critical ...

Iron deficiency and cyanotic breath-holding spells: The effectiveness of iron therapy.

Frequent cyanotic breath holding spells cause fear and severe anxiety to parents. This study aimed to evaluate clinical, laboratory and treatment characteristics of children with cyanotic breath holdi...

Cerebral Vasoreactivity Evaluated by the Breath Holding Challenge Correlates with Performance on A Cognitive Screening Test in Persons Living with Treated HIV Infection in China.

Clinically Competent and Fiscally at Risk: Impact of Debt and Financial Parameters on the Surgical Resident.

While the costs of medical training continue to increase, surgeon income and personal financial decisions may be challenged to manage this expanding debt burden. We sought to characterize the financia...

Clinical Trials [3113 Associated Clinical Trials listed on BioPortfolio]

Energy Cost for Holding a MedGem® Indirect Calorimeter

The goal of this clinical protocol is to perform a randomized crossover study to determine the energy cost of holding the MedGem® device above a person's normal resting metabolic rate (RM...

Kangaroo Holding Effects on Breast Milk

Kangaroo holding is a skin-to-skin method of holding a baby. Many research studies have investigated the maternal and infant benefits associated with kangaroo holding. The purpose of thi...

The Impact of Family Financial Support on Parental Mental Health

We have partnered with financial coaching organizations to establish what we have termed a "Medical-Financial Partnership (MFP)" that offers financial coaching to improve financial and men...

Clinic-Based Financial Coaching and Family Health and Development

This study will examine the impact of clinic-based financial coaching on parent health-related quality of life and child development measures, as well as family social needs for families w...

Intervention on Maternal Health Care in Rural China

This project aims to strengthen and improve the performance of health care system in rural China in order to improve maternal and child health. It also provides policy-makers and health se...

Companies [2502 Associated Companies listed on BioPortfolio]

China Health Holding

China Health Holding, Inc. (NASD OTCBB: CHHH) (“China Health” or “the Company”) is a development stage company, founded by the Company’s Chairman and Chief Executive Officer, Julianna Lu, in...

UMB Financial Corporation

UMB Financial Corporation (NASDAQ: UMBF) is a financial services holding company headquartered in Kansas City, Mo., offering complete banking, asset management, health spending so...

Generon BioMed Holding Ltd.

Generon BioMed Holding Ltd. is a privately held and leading Biotechnology Company located in Shanghai, China focusing on the development of innovative biological therapies for pat...

Generon BioMed Holding Ltd

Generon BioMed Holding Ltd is a privately held and leading biotechnology company located in Shanghai, China focusing on the development of innovative biological therapies for pati...

China Development Financial Holding Corporation

CDIB pioneered venture capital and investment banking in Taiwan and today it remains the predominant leader in venture capital business in Taiwan with a market share of over 30%. Along with Taiwan’s...

More Information about "China Development Financial Holding Corporation" on BioPortfolio

We have published hundreds of China Development Financial Holding Corporation news stories on BioPortfolio along with dozens of China Development Financial Holding Corporation Clinical Trials and PubMed Articles about China Development Financial Holding Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of China Development Financial Holding Corporation Companies in our database. You can also find out about relevant China Development Financial Holding Corporation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record